Silvia Dei

2.2k total citations
118 papers, 1.9k citations indexed

About

Silvia Dei is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Silvia Dei has authored 118 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 36 papers in Oncology and 35 papers in Organic Chemistry. Recurrent topics in Silvia Dei's work include Drug Transport and Resistance Mechanisms (33 papers), Receptor Mechanisms and Signaling (27 papers) and Cholinesterase and Neurodegenerative Diseases (23 papers). Silvia Dei is often cited by papers focused on Drug Transport and Resistance Mechanisms (33 papers), Receptor Mechanisms and Signaling (27 papers) and Cholinesterase and Neurodegenerative Diseases (23 papers). Silvia Dei collaborates with scholars based in Italy, France and Germany. Silvia Dei's co-authors include Elisabetta Teodori, Serena Scapecchi, María Novella Romanelli, Dina Manetti, F. Gualtieri, Cecilia Martelli, Fulvio Gualtieri, Carla Ghelardini, Luca Guandalini and Gianluca Bartolucci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Silvia Dei

118 papers receiving 1.8k citations

Peers

Silvia Dei
Silvia Dei
Citations per year, relative to Silvia Dei Silvia Dei (= 1×) peers Elisabetta Teodori

Countries citing papers authored by Silvia Dei

Since Specialization
Citations

This map shows the geographic impact of Silvia Dei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Dei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Dei more than expected).

Fields of papers citing papers by Silvia Dei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Dei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Dei. The network helps show where Silvia Dei may publish in the future.

Co-authorship network of co-authors of Silvia Dei

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Dei. A scholar is included among the top collaborators of Silvia Dei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Dei. Silvia Dei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pallecchi, Marco, et al.. (2023). Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm. International Journal of Molecular Sciences. 24(13). 11155–11155. 4 indexed citations
2.
Bartolucci, Gianluca, Marco Pallecchi, Silvia Dei, et al.. (2023). Mass Spectrometry Study about In Vitro and In Vivo Reaction between Metformin and Glucose: A Preliminary Investigation on Alternative Biological Behavior. International Journal of Molecular Sciences. 25(1). 180–180. 1 indexed citations
3.
Manetti, Dina, et al.. (2023). Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators. Molecules. 28(3). 1270–1270. 19 indexed citations
4.
Teodori, Elisabetta, et al.. (2022). The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors thatAct as Multidrug Resistance (MDR) Reversers. Current Topics in Medicinal Chemistry. 22(31). 2535–2569. 5 indexed citations
5.
Teodori, Elisabetta, Chiara Riganti, Marcella Coronnello, et al.. (2022). New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells. Journal of Medicinal Chemistry. 65(21). 14655–14672. 14 indexed citations
6.
Angeli, Andrea, Silvia Sgambellone, Alessandro Bonardi, et al.. (2021). 2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity. European Journal of Medicinal Chemistry. 228. 114026–114026. 2 indexed citations
7.
Capperucci, Antonella, Marcella Coronnello, Damiano Tanini, et al.. (2021). Synthesis of functionalised organochalcogenides and in vitro evaluation of their antioxidant activity. Bioorganic Chemistry. 110. 104812–104812. 32 indexed citations
8.
Bartolucci, Gianluca, Marialessandra Contino, Dina Manetti, et al.. (2020). 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 974–992. 12 indexed citations
9.
Bua, Silvia, Andrea Angeli, Marta Ferraroni, et al.. (2019). Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors. Bioorganic Chemistry. 91. 103130–103130. 15 indexed citations
10.
Teodori, Elisabetta, Silvia Dei, Marcella Coronnello, et al.. (2017). N -alkanol- N -cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy. European Journal of Medicinal Chemistry. 127. 586–598. 12 indexed citations
11.
Matucci, Rosanna, Cristina Bellucci, Dina Manetti, et al.. (2016). Carbachol dimers as homobivalent modulators of muscarinic receptors. Biochemical Pharmacology. 108. 90–101. 7 indexed citations
12.
Dei, Silvia, Marcella Coronnello, Gianluca Bartolucci, et al.. (2014). Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters. European Journal of Medicinal Chemistry. 87. 398–412. 22 indexed citations
13.
Orlandi, Francesca, Marcella Coronnello, Cristina Bellucci, et al.. (2012). New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry. 21(2). 456–465. 15 indexed citations
14.
Guandalini, Luca, Elisabetta Martini, Lorenzo Di Cesare Mannelli, et al.. (2012). Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs. Bioorganic & Medicinal Chemistry Letters. 22(5). 1936–1939. 7 indexed citations
15.
Martini, Elisabetta, Carla Ghelardini, Silvia Dei, et al.. (2007). Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers. Bioorganic & Medicinal Chemistry. 16(3). 1431–1443. 14 indexed citations
16.
Teodori, Elisabetta, Silvia Dei, Serena Scapecchi, & F. Gualtieri. (2002). The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Il Farmaco. 57(5). 385–415. 147 indexed citations
17.
Teodori, Elisabetta, et al.. (2001). Structure-activity relationship studies on the potent multidrug resistance (MDR) modulator 2-(3,4-dimethoxyphenyl)-2-(methylethyl)-5-[(anthr-9-yl)methylamino] pentanenitrile (MM36). Florence Research (University of Florence). 1 indexed citations
18.
Gualtieri, Fulvio, Gabriele Conti, Silvia Dei, et al.. (1994). Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 1. Tropic and 2-Phenylpropionic Acid Esters. Journal of Medicinal Chemistry. 37(11). 1704–1711. 30 indexed citations
19.
Dei, Silvia, et al.. (1994). Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(Phenylthio)-, and 2-(Phenylamino)alkanoic Acid Esters. Journal of Medicinal Chemistry. 37(11). 1712–1719. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026